Active · per the CBE, 29 September 2026

GENAMED

BE1017830106

Rechtspersoon Private limited company 1 establishment

Rue Grégoire Wincqz 4, 7060 Soignies

Active for

1 year, 9 months

Financials

Financial year 2025

GENAMED from Soignies, company number BE1017830106, closed financial year 2025 with a result of € 67,442 after tax. For that financial year GENAMED recorded revenue of € 155,000 and equity of € 72,192. Compared with financial year 2024, the result moved from € 1,750 to € 67,442. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 20, 2026.

What it is worth Growing

€ 72,192

▲ € 67,442 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 67,442

▲ € 65,693 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 72,474

▲ € 66,174 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 69,192.

People and assets in 2025

Vehicles and equipment

€ 874

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 401

▼ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,528

▲ € 17,090 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
20242025Change 2024 → 2025
Revenue € 5,000 € 155,000 ▲ € 150,000
Gross margin € 2,187 € 85,554 ▲ € 83,367
Profit after taxes € 1,750 € 67,442 ▲ € 65,693
Equity € 4,750 € 72,192 ▲ € 67,442
Total debts € 1,550 € 17,928 ▲ € 16,378
Cash € 6,300 € 72,474 ▲ € 66,174
Retained profit € 1,750 € 69,192 ▲ € 67,442
Balance sheet total € 6,300 € 90,121 ▲ € 83,821

Key figures of GENAMED, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GENAMED?

What happened at GENAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 67,442 (▲ € 65,693 vs 2024). Source: NBB ↗
  • New establishment in Soignies. KBO
  • Start of the company according to the CBE. KBO

In short

From € 1,750 profit in 2024 to € 67,442 profit in 2025.

Paid € 17,528 in corporate taxes since 2024.

Best year ever: 2025, with € 67,442 profit.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grégoire Wincqz 4

7060 Soignies

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1017.830.106
VAT number
BE 1017.830.106
Registered office
Rue Grégoire Wincqz 4, 7060 Soignies
Names & denominations
GENAMED
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 December 2024
Peppol
Active · Active since 3 Dec 2025

Frequently asked questions

What is the address of GENAMED?
The registered office of GENAMED is located at Rue Grégoire Wincqz 4, 7060 Soignies.
Is GENAMED still active?
Yes. According to the CBE (29 September 2026) GENAMED is active, legal situation “Normale toestand”, started on 23 December 2024.
Is GENAMED registered on Peppol?
Yes, GENAMED is registered on the Peppol network with ID 0208:1017830106.
What is the enterprise number of GENAMED?
The enterprise number of GENAMED is BE1017830106.
When was GENAMED founded?
GENAMED was founded on 23 December 2024.
Is GENAMED a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2024; 2 annual accounts filed, latest fiscal year 2025.